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Abstract
Background:  Inanimate surfaces have often been described as the source for outbreaks of
nosocomial infections. The aim of this review is to summarize data on the persistence of different
nosocomial pathogens on inanimate surfaces.
Methods: The literature was systematically reviewed in MedLine without language restrictions. In
addition, cited articles in a report were assessed and standard textbooks on the topic were
reviewed. All reports with experimental evidence on the duration of persistence of a nosocomial
pathogen on any type of surface were included.
Results: Most gram-positive bacteria, such as Enterococcus spp. (including VRE), Staphylococcus
aureus (including MRSA), or Streptococcus pyogenes, survive for months on dry surfaces. Many gram-
negative species, such as Acinetobacter spp., Escherichia coli, Klebsiella spp., Pseudomonas aeruginosa,
Serratia marcescens, or Shigella spp., can also survive for months. A few others, such as Bordetella
pertussis, Haemophilus influenzae, Proteus vulgaris, or Vibrio cholerae, however, persist only for days.
Mycobacteria, including Mycobacterium tuberculosis, and spore-forming bacteria, including Clostridium
difficile, can also survive for months on surfaces. Candida albicans as the most important nosocomial
fungal pathogen can survive up to 4 months on surfaces. Persistence of other yeasts, such as
Torulopsis glabrata, was described to be similar (5 months) or shorter (Candida parapsilosis, 14 days).
Most viruses from the respiratory tract, such as corona, coxsackie, influenza, SARS or rhino virus, can
persist on surfaces for a few days. Viruses from the gastrointestinal tract, such as astrovirus, HAV,
polio- or rota virus, persist for approximately 2 months. Blood-borne viruses, such as HBV or HIV,
can persist for more than one week. Herpes viruses, such as CMV or HSV type 1 and 2, have been
shown to persist from only a few hours up to 7 days.
Conclusion: The most common nosocomial pathogens may well survive or persist on surfaces for
months and can thereby be a continuous source of transmission if no regular preventive surface
disinfection is performed.
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Background
Within the global infection control community, there is
an ongoing controversy about the appropriate treatment
of inanimate surfaces in hospitals in order to prevent
transmission of nosocomial pathogens within an institu-
tion. Based on a lack of epidemiological data that would
provide evidence of a benefit for the patient from surface
disinfection (e.g., from a significant reduction of nosoco-
mial infection rates), some scientists postulate that clean-
ing of surfaces with non-antimicrobial detergents is
generally sufficient [1]. Others prefer cleaning of surfaces
with antimicrobial agents, based on data on the risk of
infection due to microbial contamination and potential
transmission of nosocomial pathogens, at least in the
immediate vicinity of patients [2-4].
New guidelines on treatment of surfaces in hospitals take
into account more parameters which are considered to be
relevant for preventing the transmission of nosocomial
pathogens, such as the type of ward or the expected fre-
quency of hand contact with a surface [5,6]. Irrespective of
the divergent opinions regarding the appropriate treat-
ment of surfaces, an important parameter for a fair scien-
tific assessment remains, that is, the persistence of
nosocomial pathogens on surfaces. The longer a nosoco-
mial pathogen persists on a surface, the longer it may be a
source of transmission and thus endanger a susceptible
patient or healthcare worker. The aim of this review was
therefore to collect and assess the data that have been pub-
lished in the last decades on persistence of all types of
nosocomial pathogens on surfaces, both in the context of
surface disinfection and the control of nosocomial out-
breaks.
Methods
Search strategy
The literature was systematically reviewed in MedLine on
the internet homepage of the National Library of Medi-
cine without language restrictions. The search was done
on 29 December 2005 and covered all years available in
MedLine. The following search terms were applied: per-
sistence, survival, surface, fomite, bacteria, virus, patho-
gen, transmission, and nosocomial. In addition, the
citations in each study found during the main search were
reviewed for potential relevance. Finally, standard text-
books on infection control, bacteriology and virology
were examined for information.
Selecting studies
All reports with experimental evidence on the duration of
persistence of a nosocomial pathogen on any type of inan-
imate surface were included. Information from textbooks
was also included, even if the chapter itself did not con-
tain experimental evidence. At least two of the investiga-
tors decided on the relevance of each report. Reports were
not blinded to the investigators so that they knew the
names of the authors of all studies.
Interpretation of studies
For a clinically relevant summary, all nosocomial patho-
gens were grouped according to their importance in caus-
ing hospital-acquired hand-transmitted infections [7] and
according to their mode of nosocomial transmission [8].
The range of the reported duration of persistence was used
as the principle outcome of the search for each nosoco-
mial pathogen. In addition, parameters with potential
influence on persistence were evaluated in all experimen-
tal studies.
Results
Persistence of bacteria
Most gram-positive bacteria, such as Enterococcus  spp.
(including VRE), Staphylococcus aureus (including MRSA),
or Streptococcus pyogenes survive for months on dry sur-
faces (Table 1). In general, there was no obvious differ-
ence in survival between multiresistant and susceptible
strains of Staphylococcus aureus and Enterococcus spp. [9].
Only in one study was such a difference suggested, but the
susceptible strains revealed a very brief survival as such
[10]. Many gram-negative species, such as Acinetobacter
spp., Escherichia coli, Klebsiella spp., Pseudomonas aerugi-
nosa, Serratia marcescens, or Shigella spp. can survive on
inanimate surfaces even for months. These species are
found among the most frequent isolates from patients
with nosocomial infections [11]. A few others, such as
Bordetella pertussis, Haemophilus influenzae, Proteus vulgaris,
or Vibrio cholerae, however, persist only for days (Table 1).
Mycobacteria – including Mycobacterium tuberculosis and
spore-forming bacteria, including Clostridium difficile –
can also survive for many months on surfaces (Table 1).
Overall, gram-negative bacteria have been described to
persist longer than gram-positive bacteria [12,13]. Humid
conditions improved persistence for most types of bacte-
ria, such as Chlamydia trachomatis [14], Listeria monocy-
togenes  [15],  Salmonella typhimurium [15],  Pseudomonas
aeruginosa  [16],  Escherichia coli [17], or other relevant
pathogens [18,19]. Only Staphylococcus aureus was found
to persist longer at low humidity [16].
Low temperatures, e.g., 4°C or 6°C, also improved per-
sistence of most types of bacteria, such Listeria monocy-
togenes  [15],  Salmonella typhimurium [15], MRSA [20],
corynebacteria [21], Escherichia coli [17,22], Helicobacter
pylori [23], and Neisseria gonorrhoeae [24].
The type of test material does not reveal a consistent
result. Although some investigators report that the type of
material has no influence on the persistence [25,26],
other authors described a longer persistence on plasticBMC Infectious Diseases 2006, 6:130 http://www.biomedcentral.com/1471-2334/6/130
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[27,28], and others yet see a survival advantage on steel
[29].
Other factors were rarely investigated and hence provide
inconsistent results. Longer persistence has been
described with higher inocula [28], in the presence of pro-
tein [13], serum [13,24], sputum [30], or without dust
[10].
Persistence of fungi
Candida albicans as the most important nosocomial fungal
pathogen can survive up to 4 months on surfaces (Table
2). Persistence of other yeasts was described to be similar
(Torulopsis glabrata 5 months) or shorter (Candida parapsi-
losis 14 days).
The presence of serum or albumin, a low temperature, and
high humidity have been described as leading to longer
persistence [31].
Persistence of viruses
Most viruses from the respiratory tract such as corona-, cox-
sackie-, influenzavirus, SARS, or rhinovirus can persist on
surfaces for a few days. Viruses from the gastrointestinal
tract, such as astrovirus, HAV, polio- and rotavirus persist
for approximately 2 months. Blood-borne viruses, such as
HBV or HIV, can persist for more than one week. Herpes
viruses such as CMV or HSV type 1 and 2 have been shown
to persist from only a few hours up to 7 days.
The influence of humidity on persistence has been
described inconsistently. For entero- [32] and rhinovirus
[33], high humidity was associated with longer persist-
ence. HSV [34] and HAV [35] can persist longer at low
humidity. For adeno- [32,34], rota- [36,37], and poliovirus
[34,35], conflicting results were reported.
For most viruses, such as astro- [38], adeno- [34], poliovirus
[34], HSV [34], and HAV [35], low temperature is associ-
ated with a longer persistence.
Inconsistent results are also reported for the influence of
type of material. Some authors described that the type of
material did not affect the persistence of echo- [39], adeno-
[39-41], parainfluenza- [39], rotavirus [41], RSV [39], polio-
[41] or norovirus [42]. Other investigators found that per-
Table 1: Persistence of clinically relevant bacteria on dry inanimate surfaces.
Type of bacterium Duration of persistence (range) Reference(s)
Acinetobacter spp. 3 days to 5 months [18, 25, 28, 29, 87, 88]
Bordetella pertussis 3 – 5 days [89, 90]
Campylobacter jejuni up to 6 days [91]
Clostridium difficile (spores) 5 months [92–94]
Chlamydia pneumoniae, C. trachomatis ≤ 30 hours [14, 95]
Chlamydia psittaci 15 days [90]
Corynebacterium diphtheriae 7 days – 6 months [90, 96]
Corynebacterium pseudotuberculosis 1–8 days [21]
Escherichia coli 1.5 hours – 16 months [12, 16, 17, 22, 28, 52, 90, 97–99]
Enterococcus spp. including VRE and VSE 5 days – 4 months [9, 26, 28, 100, 101]
Haemophilus influenzae 12 days [90]
Helicobacter pylori ≤ 90 minutes [23]
Klebsiella spp. 2 hours to > 30 months [12, 16, 28, 52, 90]
Listeria spp. 1 day – months [15, 90, 102]
Mycobacterium bovis > 2 months [13, 90]
Mycobacterium tuberculosis 1 day – 4 months [30, 90]
Neisseria gonorrhoeae 1 – 3 days [24, 27, 90]
Proteus vulgaris 1 – 2 days [90]
Pseudomonas aeruginosa 6 hours – 16 months; on dry floor: 5 weeks [12, 16, 28, 52, 99, 103, 104]
Salmonella typhi 6 hours – 4 weeks [90]
Salmonella typhimurium 10 days – 4.2 years [15, 90, 105]
Salmonella spp. 1 day [52]
Serratia marcescens 3 days – 2 months; on dry floor: 5 weeks [12, 90]
Shigella spp. 2 days – 5 months [90, 106, 107]
Staphylococcus aureus, including MRSA 7 days – 7 months [9, 10, 16, 52, 99, 108]
Streptococcus pneumoniae 1 – 20 days [90]
Streptococcus pyogenes 3 days – 6.5 months [90]
Vibrio cholerae 1 – 7 days [90, 109]BMC Infectious Diseases 2006, 6:130 http://www.biomedcentral.com/1471-2334/6/130
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sistence was favored on non-porous surfaces for influenza-
virus [43], on formica and gloves for RSV [44], and on a
telephone receiver for FCV [45].
Other parameters for a longer persistence of viruses
include the presence of fecal suspension [38] and a higher
inoculum [46].
Persistence of other nosocomial pathogens
Cryptosporidium species have been reported to survive on
dry surfaces for only 2 hours [47].
Discussion
The most relevant nosocomial pathogens can persist on
dry inanimate surfaces for months. In addition to the
duration of persistence, some studies have also identified
factors influencing persistence. A low temperature, such as
4°C or 6°C, was associated with longer persistence for
most bacteria, fungi and viruses. High humidity (e.g., >
70%) was also associated with longer persistence for most
bacteria, fungi, and viruses, although for some viruses
conflicting results were reported. A few studies also sug-
gest that a higher inoculum is associated with longer per-
sistence. The type of surface material and the type of
suspension medium, however, reveal inconsistent data.
Overall, a high inoculum of the nosocomial pathogen in
a cold room with high relative humidity will have the best
chance for long persistence.
In most reports with experimental evidence, persistence
was studied on dry surfaces using artificial contamination
of a standardized type of surface in a laboratory. In most
studies, bacteria were prepared in broth, water or saline.
Viruses were usually prepared in a cell culture medium
[48]. The main advantage is that the environmental con-
ditions are consistent regarding temperature and air
humidity. In addition, the effect of temperature or relative
humidity can only be determined under controlled condi-
tions, which are much easier to ensure in the laboratory.
However, this may not always reflect the clinical situation,
in which surfaces can be simultaneously contaminated
with various nosocomial pathogens and different types of
body fluids, secretions etc. Yet the question remains: what
is the clinical evidence for the role of surfaces in nosoco-
mial infections?
In hospitals, surfaces with hand contact are often contam-
inated with nosocomial pathogens [49-51], and may serve
as vectors for cross transmission. A single hand contact
with a contaminated surface results in a variable degree of
pathogen transfer. Transmission to hands was most suc-
cessful with Escherichia coli, Salmonella spp., Staphylococcus
aureus (all 100%) [52], Candida albicans (90%) [53], rhino
virus (61%) [54], HAV (22% – 33%) [55], and rota virus
(16%) [56,57]. Contaminated hands can transfer viruses
Common modes of transmission from inanimate surfaces to susceptible patients Figure 1
Common modes of transmission from inanimate surfaces to susceptible patients.
Contaminated 
inanimate 
surface 
Susceptible 
patient 
 
direct transmission
 
Hands of  
healthcare 
worker 
Compliance in  
hand hygiene: ~ 50% 
Table 2: Persistence of clinically relevant fungi on dry inanimate 
surfaces.
Type of fungus Duration of persistence 
(range)
Reference(s)
Candida albicans 1 – 120 days [31, 53, 99, 110]
Candida parapsilosis 14 days [110]
Torulopsis glabrata 102 – 150 days [31]BMC Infectious Diseases 2006, 6:130 http://www.biomedcentral.com/1471-2334/6/130
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to 5 more surfaces [58] or 14 other subjects [59]. Contam-
inated hands can also be the source of re-contaminating
the surface, as shown with HAV [55,58]. Compliance rates
of healthcare workers in hand hygiene are known to be
around 50% [7]. Due to the overwhelming evidence of
low compliance with hand hygiene, the risk from contam-
inated surfaces cannot be overlooked (Figure 1).
The main route of transmission is via the transiently con-
taminated hands of the healthcare worker [60-62]. An
outbreak of nosocomial infections due to Acinetobacter
baumannii in a neurosurgical intensive care unit may serve
as an example. A direct correlation was found between the
number of environmental isolates obtained during
screening and the number of patients who were colonized
or infected with the same strain during the same calender
month [63].
During outbreaks, the environment may play a significant
role for transmission of nosocomial pathogens, as sug-
gested by observational evidence. This has been described
for various types of microorganisms, such as Acinetobacter
baumannii  [64-66],  Clostridium difficile [67-69], MRSA
[65,70], Pseudomonas aeruginosa [4,65], VRE [65,71-77],
SARS [78,79], rota- [80,81], and norovirus [82]. However,
the evidence to support a role of environmental contami-
nation is not equally strong for all types of nosocomial
pathogens. For Clostridium difficile, MRSA, and VRE, data
are stronger than for other pathogens, such as Pseu-
domonas aeruginosa or Acinetobacter baumannii, of which
multiple types were detected in the environment, and
which did not always correlate with the acquired strain
[83].
The role of surface disinfection for the control of nosoco-
mial pathogens has been a contentious issue for some
time [3]. Routine treatment of clean floors with various
types of surface disinfectants (some of them had rather
poor bactericidal activity) has been described to have no
significant impact on the incidence of nosocomial infec-
tions [84]. Disinfection of surfaces in the immediate envi-
ronment of patients, however, has been described to
reduce acquisition of nosocomial pathogens such as VRE
[85] or Acinetobacter baumannii [86]. It is therefore advisa-
ble to control the spread of nosocomial pathogens at least
in the direct inanimate environment of the patient by rou-
tine surface disinfection.
Conclusion
Most nosocomial pathogens can persist on inanimate sur-
faces for weeks or even months. Our review supports cur-
rent guidelines which recommend a disinfection of
surfaces in specific patient-care areas in order to reduce
the risk of transmission of nosocomial pathogens from
inanimate surfaces to susceptible patients.
Competing interests
GK is a paid employee of Bode Chemie GmbH & Co. KG,
Hamburg, Germany.
Table 3: Persistence of clinically relevant viruses on dry inanimate surfaces.
Type of virus Duration of persistence (range) Source
Adenovirus 7 days – 3 months [32, 34, 38–41, 111]
Astrovirus 7 – 90 days [38]
Coronavirus 3 hours [112, 113]
SARS associated virus 72 – 96 hours [114]
Coxsackie virus > 2 weeks [34, 111]
Cytomegalovirus 8 hours [115]
Echovirus 7 days [39]
HAV 2 hours – 60 days [35, 38, 41]
HBV > 1 week [116]
HIV > 7 days [117–119]
Herpes simplex virus, type 1 and 2 4.5 hours – 8 weeks [34, 111, 118, 120]
Influenza virus 1 – 2 days [39, 43, 121, 122]
Norovirus and feline calici virus (FCV) 8 hours – 7 days [42, 45]
Papillomavirus 16 > 7 days [123]
Papovavirus 8 days [118]
Parvovirus > 1 year [118]
Poliovirus type 1 4 hours – < 8 days [35, 118]
Poliovirus type 2 1 day – 8 weeks [34, 38, 111]
Pseudorabies virus ≥ 7 days [124]
Respiratory syncytial virus up to 6 hours [44]
Rhinovirus 2 hours – 7 days [33, 125]
Rotavirus 6 – 60 days [36 – 38, 41]
Vacciniavirus 3 weeks – > 20 weeks [34, 126]BMC Infectious Diseases 2006, 6:130 http://www.biomedcentral.com/1471-2334/6/130
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